News | Population Health | January 04, 2017

Smartphone Apps May Help Study Cardiovascular Health, Behaviors

High participation rates help build large data set quickly, but research team reports limitations remain

smartphone apps, cardiovascular health, Stanford University study, patient self-reporting, population health

January 4, 2017 — In a study published online by JAMA Cardiology, researchers from Stanford University assessed the feasibility of measuring physical activity, fitness and sleep from smartphones. The goal was to gain insight into activity patterns associated with life satisfaction and self-reported disease.1

Studies have established the importance of physical activity, fitness, sleep and diet for cardiovascular health, yet these studies were completed with time-consuming, in-person measurements with substantial reliance on participant recall. Mobile technology, in particular advances in smartphone sensors, offers a new approach to the study of cardiovascular health and fitness. Direct measurement of activity through always-on, low-power motion chips provides a promising alternative to questionnaire-based approaches.

In 2015, Apple Inc. introduced an open-source framework to facilitate clinical research and standardization of data collection. One of the launch smartphone apps for the framework, MyHeart Counts, is a cardiovascular health study administered entirely via smartphone, incorporating direct sensor-based measurements of physical activity and fitness, as well as questionnaire assessment of sleep, lifestyle factors, risk perception and overall well-being.

From the launch to the time of the data freeze for this study (March to October 2015), the number of individuals (self-selected) who consented to participate was 48,968, representing all 50 states and the District of Columbia. Their median age was 36 years, and 82 percent were male. In total, 40,017 (82 percent of those who consented) uploaded data. Among those who consented, 42 percent completed four of the seven days of motion data collection, and 9 percent completed all seven days. Among those who consented, 82 percent filled out some portion of the questionnaires, and 10 percent completed the six-minute walk test, made available only at the end of seven days.

"Our study found five main results. First, we demonstrate the feasibility of consenting and engaging a large population across the United States using only smartphones. Second, we show that large-scale data can be gathered in real time from mobile devices, stored securely, transferred, deidentified and shared securely, including with participants. Third, we find that a data set for the six-minute walk test larger than any previously collected could be generated in weeks. Fourth, we report that state transition patterns of activity, not just absolute activity, relate to the reported presence of disease. Fifth, we conclude that there is a poor association between perceived and recorded physical activity, as well as perceived and formally estimated risk," the authors wrote.

"Most important, we also present the major challenges and limitations of mobile health research, including the skewed age and sex of participants, plus the rapid drop-off in engagement over time, with the resulting loss of data collection for several measures. To realize the promise of this novel approach to population health research, participant engagement needs to be optimized to maximize full participation of those who have expressed at least enough interest to download the app and consent to join the study."

"Large-scale, real-world assessment of physical activity, fitness and sleep using mobile devices may be a useful addition to future population health studies," the researchers concluded.

Read the article "How Smartphones and Apps May Change the Face of Healthcare."

For more information: www.jamanetwork.com/journals/jamacardiology

References

1. McConnell, M.V., Shcherbina, A., Pavlovic, A., et al. "Feasibility of Obtaining Measures of Lifestyle From a Smartphone App: The MyHeart Counts Cardiovascular Health Study," JAMA Cardiology. Published online Dec. 14, 2016. doi:10.1001/jamacardio.2016.4395


Related Content

News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
Subscribe Now